Research Article 
The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease
A. O. Y. Luk, R. C. W. Ma, W-Y. So, X-L. Yang, A. P. S. Kong, R. Ozaki, G. T. C. Ko, C-C. Chow, C. S. Cockram, J. C. N. Chan and P. C. Y. Tong
Diabetic Medicine, 2008, 25(12), 1419-1425. DOI: 10.1111/j.1464-5491.2008.02602.x
Abstract
Aim To examine the association between chronic kidney disease (CKD) and the metabolic syndrome (MetS) using both International Diabetes Federation (IDF) and National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATPIII) definitions in Chinese subjects with Type 2 diabetes.
Methods Subjects with Type 2 diabetes were categorized according to the presence or absence of MetS by IDF or NCEP-ATPIII criteria. CKD was considered present if glomerular filtration rate, calculated using the abbreviated equation developed by the Modification of Diet in Renal Disease study with Chinese modification, was < 60 ml/min per 1.73 m2. Multivariate logistic regression analysis of the association between CKD and MetS by either definition was performed.
Results Of 6350 subjects (mean age 55.1 ± 13.3 years), 3439 (54.2%) and 3204 (50.5%) had MetS by IDF and NCEP-ATPIII definitions, respectively. Using the IDF definition, the presence of MetS was not associated with CKD [odds ratio (OR) 0.96, 95% confidence interval (CI) 0.71, 1.29, P = 0.784]. In contrast, the association with CKD was significant when MetS was defined by the NCEP-ATPIII definition (OR 1.75, 95% CI 1.37, 2.24, P < 0.001). In subjects who did not have MetS (n = 2911) as defined by IDF criteria, 997 fulfilled the MetS criteria of NCEP-ATP III. The association with CKD was stronger, after adjustment for covariates, in these subjects (OR 1.42, 95% CI 1.03, 1.97, P = 0.032) compared with subjects who met IDF criteria of MetS.
Conclusion In Type 2 diabetes, NCEP-ATPIII, but not the IDF definition of MetS, identifies a subgroup of patients who have a higher risk of CKD.
ASCI-ID: 109-516
Similar Articles
The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population-based study
Diabetic Medicine, 2008, 25(5), 564-569. DOI: 10.1111/j.1464-5491.2008.02424.x
Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16Diabetic Medicine, 2008, 25(12), 1426-1432. DOI: 10.1111/j.1464-5491.2008.02592.x
Comparison of the prevalence of chronic kidney disease in Japanese patients with Type 1 and Type 2 diabetesDiabetic Medicine, 2010, 27(9), 1017-1023. DOI: 10.1111/j.1464-5491.2010.03049.x
Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liverDiabetic Medicine, 2012, 29(2), 220-226. DOI: 10.1111/j.1464-5491.2011.03427.x
The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individualsDiabetic Medicine, 2008, 25(8), 902-908.
Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based studyDiabetic Medicine, 2008, 25(6), 747-750. DOI: 10.1111/j.1464-5491.2008.02440.x
Relationship between γ-glutamyltransferase and metabolic syndrome in a Korean populationDiabetic Medicine, 2008, 25(4), 469-475. DOI: 10.1111/j.1464-5491.2008.02415.x
Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening populationDiabetic Medicine, 2009, 26(12), 1204-1211. DOI: 10.1111/j.1464-5491.2009.02864.x
Dietary glycaemic carbohydrate in relation to the metabolic syndrome in adolescents: comparison of different metabolic syndrome definitionsDiabetic Medicine, 2010, 27(7), 770-778. DOI: 10.1111/j.1464-5491.2010.03021.x
Alcohol drinking, the metabolic syndrome and diabetes in a population with high mean alcohol consumptionDiabetic Medicine, 2010, 27(11), 1241-1249. DOI: 10.1111/j.1464-5491.2010.03094.x
Elevated glucose concentrations during an oral glucose tolerance test are associated with the presence of metabolic syndrome in childhood obesityDiabetic Medicine, 2008, 25(3), 289-295. DOI: 10.1111/j.1464-5491.2007.02380.x
Education eclipses ethnicity in predicting the development of the metabolic syndrome in different ethnic groups in midlife: the Study of Women's Health Across the Nation (SWAN)Diabetic Medicine, 2008, 25(12), 1390-1399. DOI: 10.1111/j.1464-5491.2008.02596.x
The metabolic syndrome is related to albuminuria in Type 2 diabetesDiabetic Medicine, 2008, 25(12), 1412-1418. DOI: 10.1111/j.1464-5491.2008.02603.x
The metabolic syndrome: in need of a global mission statementDiabetic Medicine, 2009, 26(3), 306-309. DOI: 10.1111/j.1464-5491.2009.02681.x
Metabolic syndrome and short-term heart rate variability in young adultsDiabetic Medicine, 2009, 26(4), 354-361. DOI: 10.1111/j.1464-5491.2009.02686.x
Altered respiratory function is associated with increased metabolic risk, independently of adiposity, fitness and physical activityDiabetic Medicine, 2009, 26(4), 362-369. DOI: 10.1111/j.1464-5491.2009.02689.x
Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic reviewDiabetic Medicine, 2010, 27(5), 593-597. DOI: 10.1111/j.1464-5491.2010.02998.x
Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetesDiabetic Medicine, 2010, 27(8), 872-878. DOI: 10.1111/j.1464-5491.2010.03059.x
Association of metabolic syndrome and diabetes with subclinical coronary stenosis and plaque subtypes in middle-aged individualsDiabetic Medicine, 2011, 28(4), 493-499. DOI: 10.1111/j.1464-5491.2010.03213.x
Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approachDiabetic Medicine, 2011, 28(8), 941-947. DOI: 10.1111/j.1464-5491.2011.03330.x
Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International StudyDiabetic Medicine, 2011, 28(11), 1343-1351. DOI: 10.1111/j.1464-5491.2011.03360.x
Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liverDiabetic Medicine, 2012, 29(2), 220-226. DOI: 10.1111/j.1464-5491.2011.03427.x
Impact of increased visceral and cardiac fat on cardiometabolic risk and diseaseDiabetic Medicine, 2012, 29(5), 622-627. DOI: 10.1111/j.1464-5491.2011.03503.x
Heterogeneity in sex differences in the metabolic syndrome in Dutch white, Surinamese African and South Asian populationsDiabetic Medicine, 2012, 29(9), 1159-1164. DOI: 10.1111/j.1464-5491.2012.03616.x
Depressive symptoms linked to 1-h plasma glucose concentrations during the oral glucose tolerance test in men and women with the metabolic syndromeDiabetic Medicine, 2014, 31(5), 630-636. DOI: 10.1111/dme.12356
Diagnostic values of different definitions of metabolic syndrome to detect poor health status in Iranian adults without diabetesDiabetic Medicine, 2014, 31(7), 854-861. DOI: 10.1111/dme.12443
Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trialsDiabetic Medicine, 2008, 25(8), 924-932.
Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centresDiabetic Medicine, 2008, 25(4), 427-434. DOI: 10.1111/j.1464-5491.2008.02402.x
Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adultsDiabetic Medicine, 2008, 25(4), 476-481. DOI: 10.1111/j.1464-5491.2008.02410.x
A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetesDiabetic Medicine, 2007, 24(6), 618-625. DOI: 10.1111/j.1464-5491.2007.02141.x
Rosiglitazone RECORD study: glucose control outcomes at 18 monthsDiabetic Medicine, 2007, 24(6), 626-634. DOI: 10.1111/j.1464-5491.2007.02160.x
Lack of association between polymorphisms in the gene encoding protein tyrosine phosphatase 1B (PTPN1) and risk of Type 2 diabetesDiabetic Medicine, 2007, 24(6), 650-655. DOI: 10.1111/j.1464-5491.2007.02132.x
Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitusDiabetic Medicine, 2007, 24(7), 741-746. DOI: 10.1111/j.1464-5491.2007.02145.x
Near patient testing for glycated haemoglobin in people with Type 2 diabetes mellitus managed in primary care: acceptability and satisfactionDiabetic Medicine, 2007, 24(7), 792-795. DOI: 10.1111/j.1464-5491.2007.02175.x
Service quality for Type 2 diabetes in Australia: the patient perspectiveDiabetic Medicine, 2008, 25(5), 612-617. DOI: 10.1111/j.1464-5491.2008.02420.x
Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7-year follow-up studyDiabetic Medicine, 2008, 25(10), 1171-1177. DOI: 10.1111/j.1464-5491.2008.02567.x
Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre databaseDiabetic Medicine, 2009, 26(5), 466-473. DOI: 10.1111/j.1464-5491.2009.02720.x
Modification of diet in renal disease and Cockcroft–Gault formulas do not predict mortality (ZODIAC-6)Diabetic Medicine, 2009, 26(5), 478-482. DOI: 10.1111/j.1464-5491.2009.02709.x
Individual and contextual factors associated with follow-up use of diabetes self-management education programmes: a multisite prospective analysisDiabetic Medicine, 2009, 26(5), 510-517. DOI: 10.1111/j.1464-5491.2009.02713.x
Socioeconomic factors related to attendance at a Type 2 diabetes screening programmeDiabetic Medicine, 2009, 26(5), 518-525. DOI: 10.1111/j.1464-5491.2009.02715.x
Impact of high-fat /low-carbohydrate, high-, low-glycaemic index or low-caloric meals on glucose regulation during aerobic exercise in Type 2 diabetesDiabetic Medicine, 2009, 26(6), 589-595. DOI: 10.1111/j.1464-5491.2009.02734.x
Risk prediction models for the development of diabetes in Mauritian IndiansDiabetic Medicine, 2009, 26(10), 996-1002. DOI: 10.1111/j.1464-5491.2009.02810.x
Increasing trend in the prevalence of Type 2 diabetes and pre-diabetes in the Chinese rural and urban population in Qingdao, ChinaDiabetic Medicine, 2009, 26(12), 1220-1227. DOI: 10.1111/j.1464-5491.2009.02832.x
Which people with Type 2 diabetes achieve good control of intermediate outcomes? Population database study in a UK regionDiabetic Medicine, 2009, 26(12), 1269-1276. DOI: 10.1111/j.1464-5491.2009.02837.x
Moderating effects of coping styles on anxiety and depressive symptoms caused by psychological stress in Chinese patients with Type 2 diabetesDiabetic Medicine, 2009, 26(12), 1282-1288. DOI: 10.1111/j.1464-5491.2009.02840.x
Diabetes and other glucose metabolism abnormalities in Mexican Zapotec and Mixe IndiansDiabetic Medicine, 2010, 27(4), 412-416. DOI: 10.1111/j.1464-5491.2010.02966.x
Estimating the direct cost of Type 2 diabetes in Greece: the effects of blood glucose regulation on patient costDiabetic Medicine, 2010, 27(6), 679-684. DOI: 10.1111/j.1464-5491.2010.03004.x
The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitusDiabetic Medicine, 2010, 27(7), 762-769. DOI: 10.1111/j.1464-5491.2010.03015.x
Effects of saliva substitutes on oral status in patients with Type 2 diabetesDiabetic Medicine, 2010, 27(11), 1280-1283. DOI: 10.1111/j.1464-5491.2010.03063.x
Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implicationsDiabetic Medicine, 2010, 27(2), 136-142. DOI: 10.1111/j.1464-5491.2009.02894.x
Progression to insulin deficiency in Korean patients with Type 2 diabetes mellitus positive for anti-GAD antibodyDiabetic Medicine, 2011, 28(3), 319-324. DOI: 10.1111/j.1464-5491.2010.03186.x
The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) studyDiabetic Medicine, 2008, 25(1), 51-57. DOI: 10.1111/j.1464-5491.2007.02345.x
Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab studyDiabetic Medicine, 2008, 25(3), 296-302. DOI: 10.1111/j.1464-5491.2007.02362.x
Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetesDiabetic Medicine, 2008, 25(11), 1268-1275. DOI: 10.1111/j.1464-5491.2008.02579.x
Association between depression and concurrent Type 2 diabetes outcomes varies by diabetes regimenDiabetic Medicine, 2008, 25(11), 1324-1329. DOI: 10.1111/j.1464-5491.2008.02590.x
Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegiaDiabetic Medicine, 2008, 25(7), 856-859. DOI: 10.1111/j.1464-5491.2008.02465.x
Genome-wide linkage scans for renal function and albuminuria in Type 2 diabetes mellitus: the Diabetes Heart StudyDiabetic Medicine, 2008, 25(3), 268-276. DOI: 10.1111/j.1464-5491.2007.02361.x
Biomedical, lifestyle and psychosocial characteristics of people newly diagnosed with Type 2 diabetes: baseline data from the DESMOND randomized controlled trialDiabetic Medicine, 2008, 25(12), 1454-1461. DOI: 10.1111/j.1464-5491.2008.02620.x
Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice dailyDiabetic Medicine, 2009, 26(7), 722-728. DOI: 10.1111/j.1464-5491.2009.02752.x
High prevalence of diabetes and impaired fasting glucose in urban Latin America: the CARMELA StudyDiabetic Medicine, 2009, 26(9), 864-871. DOI: 10.1111/j.1464-5491.2009.02795.x
Risk factors associated with the dramatic increase in the prevalence of diabetes in the adult Chinese population in Qingdao, ChinaDiabetic Medicine, 2009, 26(9), 855-863. DOI: 10.1111/j.1464-5491.2009.02791.x
Smoking prevalence in Type 2 diabetes: results of the Study of Health in Pomerania (SHIP) and the German National Health Interview and Examination Survey (GNHIES)Diabetic Medicine, 2009, 26(8), 791-797. DOI: 10.1111/j.1464-5491.2009.02784.x
Prevalence of GORD (gastro-oesophageal reflux disease) in Type 2 diabetes and a comparison of clinical profiles between diabetic patients with and without GORDDiabetic Medicine, 2009, 26(3), 228-233. DOI: 10.1111/j.1464-5491.2009.02671.x
Cigarette smoking and proteinuria in Taiwanese men with Type 2 diabetes mellitusDiabetic Medicine, 2010, 27(3), 295-302. DOI: 10.1111/j.1464-5491.2010.02947.x
Are clinical practical guidelines (CPGs) useful for health services and health workforce planning? A critique of diabetes CPGsDiabetic Medicine, 2010, 27(5), 570-577. DOI: 10.1111/j.1464-5491.2010.02981.x
The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK settingDiabetic Medicine, 2010, 27(8), 887-895. DOI: 10.1111/j.1464-5491.2010.03037.x
Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathyDiabetic Medicine, 2010, 27(9), 1033-1040. DOI: 10.1111/j.1464-5491.2010.03054.x
Does intervention by an allied health professional discussing adherence to medicines improve this adherence in Type 2 diabetes?Diabetic Medicine, 2010, 27(12), 1341-1349. DOI: 10.1111/j.1464-5491.2010.03137.x
The association between the spatial QRS-T angle with cardiac autonomic neuropathy in subjects with Type 2 diabetes mellitusDiabetic Medicine, 2010, 27(12), 1420-1429. DOI: 10.1111/j.1464-5491.2010.03120.x
Prediction models for incident Type 2 diabetes mellitus in the older population: KORA S4/F4 cohort studyDiabetic Medicine, 2010, 27(10), 1116-1123. DOI: 10.1111/j.1464-5491.2010.03065.x
Comparison of the prevalence of chronic kidney disease in Japanese patients with Type 1 and Type 2 diabetesDiabetic Medicine, 2010, 27(9), 1017-1023. DOI: 10.1111/j.1464-5491.2010.03049.x
Perceived and actual diabetes risk in the Chinese and Hispanic/Latino communities in Portland, OR, USADiabetic Medicine, 2011, 28(6), 658-667. DOI: 10.1111/j.1464-5491.2010.03193.x
The humoral immune response to the inactivated influenza A (H1N1) 2009 monovalent vaccine in patients with Type 2 diabetes mellitus in KoreaDiabetic Medicine, 2011, 28(7), 815-817. DOI: 10.1111/j.1464-5491.2011.03255.x
Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitusDiabetic Medicine, 2011, 28(7), 856-864. DOI: 10.1111/j.1464-5491.2011.03240.x
Oral anti-diabetic drugs for the prevention of Type 2 diabetesDiabetic Medicine, 2011, 28(8), 948-964. DOI: 10.1111/j.1464-5491.2011.03303.x
Use of dynamic contrast-enhanced magnetic resonance imaging to evaluate the microcirculation of lower extremity muscles in patients with Type 2 diabetesDiabetic Medicine, 2011, 28(5), 618-621. DOI: 10.1111/j.1464-5491.2011.03244.x
Screening for Type 2 diabetes. Lessons from the ADDITION-Europe studyDiabetic Medicine, 2011, 28(11), 1416-1424. DOI: 10.1111/j.1464-5491.2011.03365.x
Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish populationDiabetic Medicine, 2012, 29(4), 441-452. DOI: 10.1111/j.1464-5491.2011.03450.x
Prevalence of abnormal plasma liver enzymes in older people with Type 2 diabetesDiabetic Medicine, 2012, 29(4), 488-491. DOI: 10.1111/j.1464-5491.2011.03492.x
Types of smokers in a community sample of individuals with Type 2 diabetes: a latent class analysisDiabetic Medicine, 2012, 29(5), 586-592. DOI: 10.1111/j.1464-5491.2011.03493.x
Health-related quality of life in subjects with and without Type 2 diabetes: pooled analysis of five population-based surveys in GermanyDiabetic Medicine, 2012, 29(5), 646-653. DOI: 10.1111/j.1464-5491.2011.03465.x
Vitamin D and diabetes in Koreans: analyses based on the Fourth Korea National Health and Nutrition Examination Survey (KNHANES), 2008-2009Diabetic Medicine, 2012, 29(8), 1003-1010. DOI: 10.1111/j.1464-5491.2012.03575.x
Increased apoB/A-I ratio independently associated with Type 2 diabetes mellitus: cross-sectional study in a Korean populationDiabetic Medicine, 2012, 29(9), 1165-1170. DOI: 10.1111/j.1464-5491.2012.03622.x
Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetesDiabetic Medicine, 2012, 29(9), 1184-1190. DOI: 10.1111/j.1464-5491.2012.03613.x